Corporate Background
Nexus Dx was formed by Bay City Capital to take advantage of current market opportunities by consolidating products and technologies to create a company dedicated to improving patient outcomes and healthcare economics via decentralized blood diagnostics.
Company Milestones
- November 2010: International Technidyne Corporation Acquired by Warburg Pincus. International Technidyne Corporation Subsequently Merges With Nexus Dx To Create Global Provider of Point-of-Care Testing Systems and Advanced Diagnostic Solutions.
- September 2009: Nexus Dx merged with HX Diagnostics, a Bay Area diagnostics company that is developing rapid diagnostics for seasonal and pandemic influenza and other respiratory illnesses.
- July 2009: Nexus Dx acquired the point of care assets of Nanogen, Inc. Jim Merselis joined the new entity as President and CEO.
Contact us to learn more.